Live Breaking News & Updates on Calithera Biosciences Inc

Stay updated with breaking news from Calithera biosciences inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

StockNews.com Begins Coverage on Calithera Biosciences (NASDAQ:CALA)

Analysts at StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Free Report) in a report issued on Tuesday. The firm set a “hold” rating on the biotechnology company’s stock. Calithera Biosciences Stock Performance NASDAQ:CALA opened at $0.02 on Tuesday. The company has a fifty day moving average of $0.02 and a two-hundred […] ....

South San Francisco , United States , Calithera Biosciences , Calithera Biosciences Inc , Get Free Report , Calithera Biosciences Daily , Nasdaq Cala , Initiated Coverage , Stocknews Com ,

StockNews.com Initiates Coverage on Calithera Biosciences (NASDAQ:CALA)

StockNews.com Initiates Coverage on Calithera Biosciences (NASDAQ:CALA)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , South San Francisco , Calithera Biosciences , Alyeska Investment Group , Goldman Sachs Group Inc , Vanguard Group Inc , Renaissance Technologies , Affinity Asset Advisors , Calithera Biosciences Inc , Get Free Report , Sachs Group , Calithera Biosciences Daily ,

Calithera Biosciences (NASDAQ:CALA) Earns Hold Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a research note published on Monday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Calithera Biosciences Price Performance CALA opened at $0.02 on Monday. The stock has a 50-day moving average price of $0.03 and a 200-day moving […] ....

South San Francisco , United States , Calithera Biosciences , Renaissance Technologies , Alyeska Investment Group , Affinity Asset Advisors , Goldman Sachs Group Inc , Vanguard Group Inc , Calithera Biosciences Inc , Free Report , Sachs Group , Asset Advisors , Vanguard Group , Get Free Report , Calithera Biosciences Daily ,

Calithera Biosciences (NASDAQ:CALA) Research Coverage Started at StockNews.com

Equities research analysts at StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Free Report) in a research note issued on Friday. The firm set a “hold” rating on the biotechnology company’s stock. Calithera Biosciences Price Performance NASDAQ:CALA opened at $0.03 on Friday. Calithera Biosciences has a fifty-two week low of $0.01 and […] ....

South San Francisco , United States , Calithera Biosciences , Vanguard Group Inc , Calithera Biosciences Inc , Alyeska Investment Group , Affinity Asset Advisors , Renaissance Technologies , Goldman Sachs Group Inc , Calithera Biosciences Company Profile , Get Free Report , Sachs Group , Calithera Biosciences Daily , Nasdaq Cala , Initiated Coverage , Stocknews Com ,